InvestorsHub Logo
Followers 44
Posts 6925
Boards Moderated 0
Alias Born 03/18/2016

Re: None

Thursday, 03/26/2020 2:06:32 PM

Thursday, March 26, 2020 2:06:32 PM

Post# of 43722
https://www.drugtargetreview.com/news/58326/collaboration-initiated-to-develop-covid-19-immunotherapy/
Repost I know but from today...
Great quote..."It is suggested, based on studies with H1N1, that a LEAPS coronavirus – SARS-CoV-2 immunotherapy may reduce or prevent the progression of the viral infection and prevent tissue damage from inflammation resulting from lung infiltration by the virus. By stimulating the correct immune responses without producing unwanted inflammatory responses associated with lung tissue damage, LEAPS immunotherapy may be particularly beneficial in those patients who are at highest risk of dying from COVID-19."
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CVM News